Skip to content


Follow us on Twitter for more news.


Long-acting PrEP is just as effective as oral PrEP – how much should we be willing to pay?

February 1, 2022

Dr. Anne Neilan discusses how the presence of highly effective oral pre-exposure prophylaxis (PrEP) limits the additional price that payers should be willing to pay for long-acting injectable cabotegravir (CAB-LA).

Neilan AM et al. (2022). Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States: A Cost-Effectiveness Analysis. Ann Intern Med Image courtesy of Annals of Internal Medicine.

Use of e-cigarettes plus tobacco cigarettes linked to higher incidence of respiratory symptoms

April 22, 2021

Dr. Krishna Reddy discusses the increased risk of cough and wheeze in people who use both e-cigarettes and tobacco cigarettes and the implications for those using e-cigarettes in an effort to stop smoking tobacco cigarettes.

Reddy KP et al. (2021). Respiratory symptom incidence among people using electronic cigarettes, combustible tobacco, or both. Am J Respir Crit Care Med. Image courtesy of macrovector and macrovector_official on

Clinical Trial Reveals Warning Signs Over Effectiveness of “Wonder Drug” in Sub-Saharan Africa

December 1, 2020

Dr. Mark Siedner and global colleagues report sobering data that drug resistance to older HIV drugs might also threaten the success of the newest treatment regimen.

Image courtesy of Siedner MJ et al. (2020). Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nature Communications.

Microsimulation Model Identifies Cost-Effective Public Health Strategies to Combat COVID-19

November 13, 2020

Dr. Krishna Reddy and colleagues find that active case finding and isolation could control COVID-19 spread and save lives while being cost-effective in South Africa.

Image courtesy of Reddy KP et al. (2020). Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Global Health

Research Supports More Frequent HIV Testing Among High-Risk Young Men Who Have Sex With Men

August 5, 2020

Dr. Anne Neilan discusses the clinical benefit and cost-effectiveness of quarterly HIV testing for high-risk young men who have sex with men in the U.S.

Image courtesy of Neilan AM et al. (2020). Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. Clinical Infectious Diseases, ciaa1061.

Using Models to Project CKRT Shortages During the COVID-19 Pandemic

July 27, 2020

Dr. Yuvaram Reddy and colleagues report findings from models that project shortages in continuous kidney replacement therapy (CKRT) during the COVID-19 pandemic.

Image courtesy of Reddy YN et al. (2020). Estimating shortages in capacity to deliver continuous kidney replacement therapy during the COVID-19 pandemic in the United States. American Journal of Kidney Diseases

A Creative Approach to Contraceptive Care in South Africa

February 20, 2020

Dr. Ingrid Bassett discusses a new initiative to provide women in South Africa with contraception and PrEP services in hair salons.

MGH Research Scholar is a Determined Policy Advocate

Rochelle Walensky, MD, MPH, chief of the Division of Infectious Disease discusses her congressional testimony, public health advocacy and the challenges of infectious diseases.